Immunocidin Partner I know that this all but forgotten canine cancer approval is no longer on anyone's radar, but I understand that they will have a marketing in place any time now...Remember the canine cancer (MCC derivative) that was approved a couple of weeks back. It sounds as if it is related to that other drug thing they have currently immersed in a 100 mil global trial.
For some reason it was overshadowed and buried by some long-needed expense trimming.
Anyhow, most of you who follow Plovie know that new drug approvals/partnerships rarely move a share price as initial sales could be as a full quarter away, but I would submit that it just might in this rare case.
I hear that it will be one of three partners, maybe down to two this week, who will be serving the NA marketplace. Apparently there is a fair amount of excitement around its launch.
A 62 mil market cap may be a bit of a stretch but I think BNC can earn its way in over the next moth or two.